Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2020 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Recursion Pharmaceuticals, Inc. | 8 | Q3 2023 | 50.0% |
Evolv Technologies Holdings, Inc. | 8 | Q3 2023 | 47.1% |
Rocket Lab USA, Inc. | 5 | Q4 2022 | 11.6% |
Mind Medicine (MindMed) Inc. | 5 | Q4 2022 | 4.1% |
Embark Trucks, Inc. | 4 | Q2 2023 | 18.7% |
Roivant Sciences Ltd. | 4 | Q3 2023 | 0.2% |
Embark Trucks, Inc. | 3 | Q2 2022 | 79.7% |
Rocket Lab USA, Inc. | 3 | Q3 2023 | 13.0% |
Mind Medicine (MindMed) Inc. | 3 | Q3 2023 | 0.3% |
View Data Collective IV GP, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-11-14 |
13F-HR/A | 2022-11-14 |
View Data Collective IV GP, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.